MARKET WIRE NEWS

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-09 11:07:47 ET

Biodesix, Inc. (BDSX)

Q2 2025 Earnings Conference Call

August 07 2025, 04:30 PM ET

Company Participants

Robin Harper Cowie - CFO, Secretary & Treasurer

Scott Hutton - President, CEO & Director

Conference Call Participants

Alexander Davis Vukasin - Canaccord Genuity Corp., Research Division

Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division

Thomas Flaten - Lake Street Capital Markets, LLC, Research Division

William Ruby - TD Cowen, Research Division

William Bishop Bonello - Craig-Hallum Capital Group LLC, Research Division

Christopher F. Brinzey - Westwicke Partners, LLC

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....

Read the full article on Seeking Alpha

For further details see:

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript
Biodesix Inc.

NASDAQ: BDSX

BDSX Trading

1.26% G/L:

$19.28 Last:

37,157 Volume:

$19.30 Open:

mwn-app Ad 300

BDSX Latest News

February 26, 2026 07:14:05 pm
Biodesix (BDSX) Q4 2025 Earnings Call Transcript

BDSX Stock Data

$83,296,022
3,850,552
19.65%
10
N/A
Medical Diagnostics & Screening
Healthcare
US
Louisville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App